Immix Biopharma Inc

IMMXNASDAQ · USD
11.70USD0.00 (-1.85%)
2310

Immix Biopharma Inc (IMMX) Option Chain

As of September 23, 2026, Immix Biopharma Inc is trading at $11.70, a -1.85% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 163.1%. IV Rank is 68%.

Read more

Tracking the IMMX option chain helps you see every strike and expiry on Immix Biopharma Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Immix Biopharma Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IMMX options activity at a glance. Use our scanner to monitor the IMMX option chain in real time and filter for the IMMX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IMMX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IMMX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IMMX stock options are being actively traded and where they are not.

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab.

The company was incorporated in 2012 and is headquartered in Los Angeles, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Immix Biopharma Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen IMMX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IMMX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile74.60% Elevated
  • Market cap (M$)837
  • 52 weeks high-22.52%
  • 52 weeks low490.91%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$23.86
    103.93% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-06
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.88
  • EPS growth next 5 years16.22%

As of September 23, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
12.80700.904.203.506.707.50-37.08—1.800.001.800087.20
37.2632311.501.702.104.3010.00-16.110.350.900.000.63259662.74
61.961691911.700.001.352.0512.50+4.871.252.550.801.1004138.04
79.342,7991630.900.000.801.0015.00+25.842.204.603.300.100020.66
89.493002.800.00—2.8017.50+46.814.406.505.80-0.350010.51

As of September 23, 2026

Scan the full option chain in one place

Browse the full IMMX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial